ESMO Colloquium supported by Lilly Oncology in collaboration with MSD - How to best use immune checkpoint inhibitors in NSCLC: Single agents or combined with chemotherapy? ESMO Colloquium

First-line immunotherapy options for patients without an oncogene driver

Lecture Time
11:50 - 12:10
Speakers
  • R. Califano (Manchester, United Kingdom)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
11:45 - 13:15
Authors
  • R. Califano (Manchester, United Kingdom)